Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis

Fig. 5

Kaplan–Meier plots for validations of FRGS in a cohort of ccRCC patients who received immunotherapy. A, B The outcome of patients with different CAF risk group in ccRCC patients with immunotherapy: PFS (A) and OS (B). C, D The outcome of patients with different drug response in ccRCC patients with different CAF risk group: PFS (A) and OS (B)

Back to article page

Molecular Medicine

ISSN: 1528-3658